BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 15710226)

  • 1. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis.
    Poupon R; Chrétien Y; Chazouillères O; Poupon RE
    J Hepatol; 2005 Mar; 42(3):418-9. PubMed ID: 15710226
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary biliary cirrhosis and pregnancy: benefit of ursodeoxycholic acid therapy].
    Pajares Villarroya R; Castillo Grau P; Manceñido Marcos N; Navajas León FJ; Hervías Cruz D; Erdozain Sosa JC; Segura Cabral JM
    Gastroenterol Hepatol; 2003 Nov; 26(9):615. PubMed ID: 14642247
    [No Abstract]   [Full Text] [Related]  

  • 3. Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis.
    Vítek L; Zelenková M; Brůha R
    Dig Liver Dis; 2010 Dec; 42(12):911-2. PubMed ID: 20619755
    [No Abstract]   [Full Text] [Related]  

  • 4. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
    Levy C; Angulo P
    Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
    [No Abstract]   [Full Text] [Related]  

  • 5. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
    Lindor K
    N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
    [No Abstract]   [Full Text] [Related]  

  • 6. The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable.
    Yan G; Erik C; Gluud C
    Am J Gastroenterol; 2007 Feb; 102(2):464-5. PubMed ID: 17311669
    [No Abstract]   [Full Text] [Related]  

  • 7. Practice variation in treatment of primary biliary cirrhosis and effect on clinical outcomes.
    Talwalkar JA; Gossard AA
    Hepatology; 2008 Apr; 47(4):1428. PubMed ID: 18366110
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary biliary cirrhosis and ursodeoxycholic acid therapy].
    Makino I
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):399-403. PubMed ID: 8691003
    [No Abstract]   [Full Text] [Related]  

  • 9. Patients and patience: the pitfalls of primary biliary cirrhosis trials.
    Mayo MJ
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):552-3. PubMed ID: 16327817
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary biliary cirrhosis.
    Gong Y; Christensen E; Gluud C
    N Engl J Med; 2005 Dec; 353(25):2719-20; author reply 2719-20. PubMed ID: 16379089
    [No Abstract]   [Full Text] [Related]  

  • 11. Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win?
    Benner KG
    Liver Transpl Surg; 1999 Jul; 5(4):334-7. PubMed ID: 10388507
    [No Abstract]   [Full Text] [Related]  

  • 12. Methotrexate for treatment of primary biliary cirrhosis.
    Bonis PA; Kaplan M
    Hepatology; 2006 Mar; 43(3):632; author reply 632-3. PubMed ID: 16496314
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol.
    Kaplan MM; Poupon R
    Hepatology; 2009 Aug; 50(2):652. PubMed ID: 19309721
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
    Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
    Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophils and primary biliary cirrhosis-stoking the fire?
    Neuberger J
    Hepatology; 1999 Jul; 30(1):335-7. PubMed ID: 10385676
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
    Walker LJ; Newton J; Jones DE; Bassendine MF
    Hepatology; 2009 Jan; 49(1):337-8; author reply 338. PubMed ID: 19035342
    [No Abstract]   [Full Text] [Related]  

  • 18. How, why, and when does primary biliary cirrhosis recur after liver transplantation?
    Williams R; Gershwin ME
    Liver Transpl; 2007 Sep; 13(9):1214-6. PubMed ID: 17763403
    [No Abstract]   [Full Text] [Related]  

  • 19. Ursodeoxycholic acid for primary biliary cirrhosis.
    Lindor KD; Poupon R; Poupon R; Heathcote EJ; Therneau T
    Lancet; 2000 Feb; 355(9204):657-8. PubMed ID: 10697011
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.